French Industrial REITs Stock News

AXA SA recently appointed David Jones as chief underwriting officer for its UK Lloyd's Retail business, with Jones bringing over two decades of industry experience and set to assume the role in London from spring 2026. This leadership transition places the focus on underwriting strategy, an area central to AXA XL’s ongoing efforts in insurance innovation and market development in the UK. We'll explore how David Jones’s appointment could influence AXA’s investment narrative through potential...

JCDecaux (ENXTPA:DEC) shares have dipped in recent trading sessions, losing 2% over the past day and about 7% since the start of the year. Investors may be taking a closer look at the company’s value proposition amid these moves. See our latest analysis for JCDecaux. JCDecaux’s 1-day share price return of -2.27% continues a pattern of softening momentum, which points to renewed caution from investors after a period of muted trading. Despite this, the company’s total shareholder return has...

As the pan-European STOXX Europe 600 Index experienced a modest rise, bolstered by the reopening of the U.S. federal government, cooling sentiment on artificial intelligence tempered broader market gains. In this environment, identifying stocks trading below their estimated worth can offer potential opportunities for investors seeking value amidst fluctuating economic conditions and investor sentiment.

Key Insights The considerable ownership by private companies in Casino Guichard-Perrachon indicates that they...

Pluxee N.V.'s ( EPA:PLX ) dividend will be increasing from last year's payment of the same period to €0.38 on 23rd of...

Let's talk about the popular Hermès International Société en commandite par actions ( EPA:RMS ). The company's shares...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

Ubisoft Entertainment (ENXTPA:UBI) has announced a delay in releasing its first-half 2025-26 results and requested a halt in trading of its shares and bonds on Euronext. This move is drawing plenty of investor attention. See our latest analysis for Ubisoft Entertainment. The trading halt and results delay follow a rough patch for Ubisoft’s shareholders, with a year-to-date share price return of -47.36% and a one-year total shareholder return of -49.91%. While this week’s 11.31% share price...

Last week, you might have seen that OVH Groupe S.A. ( EPA:OVH ) released its yearly result to the market. The early...

Arkema S.A.'s ( EPA:AKE ) stock was strong despite it releasing a soft earnings report last week. We think that...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

EssoF (ENXTPA:ES) just announced a hefty €60.21 per share special dividend, set for November 14, 2025, after shareholders gave the green light during the recent Combined General Meeting. Investors are paying close attention. See our latest analysis for EssoF. That extraordinary dividend comes after an eventful year for EssoF, with the share price recently closing at €47.44. Despite a sharp drop in price over the past month and year-to-date, investors who held on for the past twelve months...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

It's not a stretch to say that Calibre's ( EPA:ALIBR ) price-to-sales (or "P/S") ratio of 0.1x right now seems quite...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Planisware SAS (ENXTPA:PLNW) shares have held steady over the past day, continuing a trend that investors have seen this month. The stock is up 2% over the past week and about 1% for the month. See our latest analysis for Planisware SAS. While Planisware SAS has shown some recent momentum with an 11.98% share price return over the past 90 days, its year-to-date share price return is still down 26.36%. Over the longer haul, the one-year total shareholder return stands at -10.74%, which...

On October 31, 2025, DM announced a partnership with VusionGroup to implement the EdgeSense digital shelf platform across approximately 70 stores, with around 20 stores already activated. This rollout leverages advanced IoT, computer vision, and AI capabilities to reduce operational complexity and improve both employee workflows and the customer experience in DM stores. We'll explore how the EdgeSense partnership supports VusionGroup’s strategy of driving retail digital transformation...

In recent weeks, European markets have experienced a pullback, with the pan-European STOXX Europe 600 Index closing lower amid concerns over artificial intelligence-related stock valuations. As investors navigate these fluctuating conditions, identifying stocks that might be trading below their estimated value can present opportunities for those seeking to capitalize on potential market inefficiencies.

As European markets face a pullback with the pan-European STOXX Europe 600 Index ending 1.24% lower due to concerns over AI-related stock valuations, investors are increasingly looking for stability amid fluctuating sentiment. In such an environment, dividend stocks can provide consistent income and potential resilience against market volatility, making them attractive options for enhancing portfolio stability.

Argan (ENXTPA:ARG) has just completed a 9,000 sq.m logistics facility in Vendin-le-Vieil, securing a 12-year lease with a major international logistics group. This project combines operational scale with a focus on sustainability. See our latest analysis for Argan. Following this milestone in Vendin-le-Vieil, Argan’s momentum has been steady this year. The stock’s share price return year-to-date sits at a solid 10.31%. Over the past year, total shareholder return reached 4.26%, signaling...

ABIVAX Société Anonyme (ENXTPA:ABVX) just shared patient-reported outcomes from its Phase 3 trial for obefazimod in adults with ulcerative colitis. These findings shed light on how patients actually experience the drug’s effects beyond clinical endpoints. See our latest analysis for ABIVAX Société Anonyme. After releasing the latest trial results and earning a spot in the Euronext 150 Index, ABIVAX Société Anonyme's stock has been on an impressive run. Momentum remains strong, with a 90-day...

Claranova SE ( EPA:CLA ) shares have had a horrible month, losing 26% after a relatively good period beforehand...

Key Insights The projected fair value for Sopra Steria Group is €252 based on 2 Stage Free Cash Flow to Equity Sopra...